Center-Authored Papers

Filters: Author is Marty, Francisco M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Marty FM, Boeckh MJ.  2011.  Maribavir and human cytomegalovirus-what happened in the clinical trials and why might the drug have failed? Current opinion in virology. 1(6):555-62. Abstract
Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Momméja-Marin H et al..  2013.  CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.. The New England journal of medicine. 369(13):1227-36. Abstract
Marty FM, Ljungman P, Papanicolaou GA, Winston DJ, Chemaly RF, Strasfeld L, Young J-AH, Rodriguez T, Maertens J, Schmitt M et al..  2011.  Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial.. The Lancet infectious diseases. 11(4):284-92. Abstract
Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR, Alangaden GJ, Brown JM, Fredricks DN, Heinz WJ et al..  2016.  Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.. The Lancet. Infectious diseases. Abstract
Y
Young J-AH, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Dubberke ER et al..  2015.  Infections following Transplantation of Bone Marrow or Peripheral-Blood Stem Cells from Unrelated Donors.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract